Alpha Teknova, Inc. (TKNO)
Company Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally.
Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics.
The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions.
The company was founded in 1996 and is headquartered in Hollister, California.
| Country | United States |
| Founded | 1996 |
| IPO Date | Jun 25, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 237 |
| CEO | Mr. Stephen Gunstream |
Contact Details
Address:
2451 Bert Drive Hollister, California 95023 United States | |
| Phone | (831) 637-1100 |
| Website | teknova.com |
Stock Details
| Ticker Symbol | TKNO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $16.00 |
| CIK Code | 0001850902 |
| CUSIP Number | 02080L102 |
| ISIN Number | US02080L1026 |
| Employer ID | 94-3368109 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Stephen Gunstream | President, Chief Executive Officer and Director |
| Matthew C. Lowell | Chief Financial Officer |
| Ken Gelhaus | Chief Commercial Officer |
| Damon A. Terrill | General Counsel, Chief Compliance Officer and Secretary |
| Jennifer Henry | Senior Vice President of Marketing |
| Lisa Hood McCann | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 15, 2023 | 8-K | Current Report |
| Mar 13, 2023 | 8-K | Current Report |
| Jan 30, 2023 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 14, 2022 | 10-Q | Quarterly Report |
| Nov 9, 2022 | 8-K | Current Report |
| Aug 11, 2022 | 10-Q | Quarterly Report |
| Aug 10, 2022 | 8-K | Current Report |
| Jul 12, 2022 | EFFECT | Notice of Effectiveness |
| Jul 1, 2022 | S-3 | Registration statement under Securities Act of 1933 |
| Jun 3, 2022 | 8-K | Current Report |